NCT01876433View on ClinicalTrials.gov

Beta 3 Agonist Treatment in Heart Failure

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Chronic Heart Failure With Reduced Ejection Fraction (HFrEF)
Interventions
DRUG

Mirabegron

DRUG

Placebo

Trial Locations (3)

2100

Department of Cardiology, The Heart Centre, Rigshospitalet Copenhagen University Hospital., Copenhagen Ø

Unknown

Monash Center of Cardiovascular Research., Melbourne

Department of Cardiology, Royal North Shore Hospital., Sydney

All Listed Sponsors
lead

Henning Bundgaard

OTHER

NCT01876433 - Beta 3 Agonist Treatment in Heart Failure | Biotech Hunter | Biotech Hunter